THP 005
Alternative Names: THP-005Latest Information Update: 27 Mar 2025
At a glance
- Originator THPharm
- Class Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Obesity
Most Recent Events
- 28 Jan 2025 Early research in Obesity in South Korea (IM), prior to January 2025 (THPharm pipeline, January 2025)